Chemical identity

N1,N6 [ 1,3-(1-Oxopropylene)] Ibrutinib

CAS 1917333-91-5 · C28H26N6O3

01Identity

Identifiers and names for this exact compound. Empty fields are left unassigned.

Lazychem IDLC-16863
PubChem CID121314196
NameN1,N6 [ 1,3-(1-Oxopropylene)] Ibrutinib
CAS RN1917333-91-5
Molecular formulaC28H26N6O3
Molecular weight494.56 g/mol
IUPAC name(R)-8-(1-acryloylpiperidin-3-yl)-10-(4-phenoxyphenyl)-3,4-dihydropyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one
InChIKeyFSCNEJORXHNHBP-HXUWFJFHSA-N

02Structure identifiers

2D structurePubChem CID 121314196
2D structure: N1,N6 [ 1,3-(1-Oxopropylene)] Ibrutinib, CAS 1917333-91-5
Structure of N1,N6 [ 1,3-(1-Oxopropylene)] Ibrutinib (CAS 1917333-91-5). LazyChem record. Source identity: PubChem CID 121314196. Confirm the identifiers before analytical use.Download structure image

Structure facts for this exact identity.

Molecular formulaC28H26N6O3
InChIKeyFSCNEJORXHNHBP-HXUWFJFHSA-N
Ring count6
Defined stereocentres1
Unassigned stereocentres0
SMILESC=CC(=O)N1CCC[C@H](C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C6=NC(=O)CCN6C=N3
InChIInChI=1S/C28H26N6O3/c1-2-24(36)32-15-6-7-20(17-32)34-27-25(28-30-23(35)14-16-33(28)18-29-27)26(31-34)19-10-12-22(13-11-19)37-21-8-4-3-5-9-21/h2-5,8-13,18,20H,1,6-7,14-17H2/t20-/m1/s1

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge-and-dash depiction is shown above.

Defined stereocentres12D structure
Unassigned stereocentres02D structure
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04India status for this compound

These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.

NDPS / RCSNOT FOUND IN REVIEWED ENTRIESCAS 1917333-91-5 was not found in the reviewed exact-identity entries. Generic, class, analogue, salt and isomer provisions were not evaluated.
SCOMETNOT FOUND IN REVIEWED CAS ENTRIESCAS 1917333-91-5 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated.

05Names and relationships

Associated parent compound

Ibrutinib

View API and impurity family

Other names

  • Ibrutinib Impurity 23
  • (R)-8-(1-Acryloylpiperidin-3-yl)-10-(4-phenoxyphenyl)-3,4-dihydropyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one (Ibrutinib Impurity)
  • (R)-8-(1-ACRYLOYLPIPERIDIN-3-YL)-10-(4-PHENOXYPHENYL)-3,4-DIHYDROPYRAZOLO[4,3-E]PYRIMIDO[1,2-C]PYRIMIDIN-2(8H)-ONE
  • 3,4-Dihydro-8-[(3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-10-(4-phenoxyphenyl)pyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one
  • orb3181394
  • 3-(4-phenoxyphenyl)-5-[(3R)-1-prop-2-enoylpiperidin-3-yl]-4,5,7,9,13-pentazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7-tetraen-12-one
  • CS-0167157

Related records from the same parent family

06Documented history

Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.

No dated history available

No verified discovery, first report, occurrence, use or issue event is currently available for this identity.

07Sources